## Abstract No causative or curative therapy exists for the polyneuropathy associated with antibodies to myelinโassociated glycoprotein (antiโMAG). Rituximab is a mouseโhuman chimeric antibody that specifically eliminates Bโcells and Bโcell precursors. Preliminary results suggest a beneficial effec
Worsening after rituximab treatment in anti-mag neuropathy
โ Scribed by Laura Broglio; Giuseppe Lauria
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 41 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We compared the binding of human antibodies from patients with neuropathy to the myelin-associated glycoprotein (MAG), to its cross-reactive glycolipid sulfoglucuronyl paragloboside (SGPG), and to sections of peripheral nerve. Titers were correlated with the clinical presentation and results of elec
Polyneuropathy with monoclonal gammopathy usually is considered a nosological entity different from chronic inflammatory demyelinating polyneuropathy (CIDP). Criteria proposed by the American Academy of Neurology AIDS Task Force (1991), however, show monoclonal gammopathy to be a condition concurren